News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Expression Pathology Aids Research in Identifying Biomarkers of Lung Cancer Metastasis and Survival



2/19/2008 12:31:07 PM

GAITHERSBURG, Md.--(BUSINESS WIRE)--Expression Pathology Inc. (EPI), a leader in tissue proteomics, announced that researchers at Tokyo Medical University, using the company’s tissue microproteomics technologies, identified protein biomarkers associated with lung cancer metastasis, which were further studied for correlation to clinical outcomes. The researchers used EPI’s Liquid Tissue® reagents and Director™ laser microdissection slides to analyze formalin-fixed paraffin-embedded (FFPE) tissue samples by mass spectrometry.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES